Literature DB >> 7835024

Eosinophilic hepatitis: a new feature of the clinical spectrum of the eosinophilia-myalgia syndrome.

P Martinez-Osuna1, C G Espinoza, M L Cuellar, G E Cabrera, L H Silveira, L R Espinoza.   

Abstract

The eosinophilia-myalgia syndrome associated with L-tryptophan-containing products is highlighted by eosinophilia, incapacitating myalgias, and diverse multisystemic manifestations. In addition to involvement of the skin, skeletal muscle, and peripheral nerves, visceral damage has been quite prominent, particularly affecting the lungs, the heart, and the liver. Hepatic involvement has been manifested by altered liver tests but is clinically silent. We report the unique case of a woman with this syndrome who developed abdominal pain, a clinical picture of hepatitis and chronically abnormal liver tests. Histologic examination of the liver disclosed eosinophilic hepatitis with piecemeal necrosis. The occurrence of clinically overt hepatic involvement has not been reported previously. Potential mechanisms of liver damage in eosinophilia-myalgia syndromes are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7835024     DOI: 10.1007/bf02242958

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  12 in total

1.  Characterization of "peak E," a novel amino acid associated with eosinophilia-myalgia syndrome.

Authors:  A N Mayeno; F Lin; C S Foote; D A Loegering; M M Ames; C W Hedberg; G J Gleich
Journal:  Science       Date:  1990-12-21       Impact factor: 47.728

2.  Eosinophil-induced chronic active hepatitis in the idiopathic hypereosinophilic syndrome.

Authors:  A Foong; J V Scholes; G J Gleich; G M Kephart; P R Holt
Journal:  Hepatology       Date:  1991-06       Impact factor: 17.425

Review 3.  Drug-induced liver disease.

Authors:  J H Lewis; H J Zimmerman
Journal:  Med Clin North Am       Date:  1989-07       Impact factor: 5.456

Review 4.  The cause and pathogenesis of the eosinophilia-myalgia syndrome.

Authors:  J Varga; J Uitto; S A Jimenez
Journal:  Ann Intern Med       Date:  1992-01-15       Impact factor: 25.391

Review 5.  NIH conference. Gastrointestinal surgery for severe obesity. Consensus Development Conference Panel.

Authors: 
Journal:  Ann Intern Med       Date:  1991-12-15       Impact factor: 25.391

6.  Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.

Authors:  P A Hertzman; W L Blevins; J Mayer; B Greenfield; M Ting; G J Gleich
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

7.  Clinical follow-up and immunogenetic studies of 32 patients with eosinophilia-myalgia syndrome.

Authors:  L D Kaufman; B L Gruber; P K Gregersen
Journal:  Lancet       Date:  1991-05-04       Impact factor: 79.321

Review 8.  Prolactin, immunoregulation, and autoimmune diseases.

Authors:  L J Jara; C Lavalle; A Fraga; C Gómez-Sanchez; L H Silveira; P Martínez-Osuna; B F Germain; L R Espinoza
Journal:  Semin Arthritis Rheum       Date:  1991-04       Impact factor: 5.532

9.  Eosinophilic fasciitis presenting with a reactive hepatitis.

Authors:  A E Loeliger; H R van den Brink; R H Derksen; J W Bijlsma
Journal:  Clin Rheumatol       Date:  1991-12       Impact factor: 2.980

10.  Relapsing eosinophilic myositis.

Authors:  G D Sladek; F B Vasey; B Sieger; D A Behnke; B F Germain; L R Espinoza
Journal:  J Rheumatol       Date:  1983-06       Impact factor: 4.666

View more
  1 in total

Review 1.  Immune cells in liver regeneration.

Authors:  Na Li; Jinlian Hua
Journal:  Oncotarget       Date:  2017-01-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.